← HB1416 bill details

Substantive final action

HB1416

House: THIRD READING

Non-opioid treatment; terms; preferred drug lists; discretion; drug treatment; United States Food and Drug Administration; coverage; non-opioid drugs; reimbursement; effective date.

Passed House March 3, 2025⭐ Substantive final action

90Yea
7Nay
0Not voting
2Absent

Yea (90)

Nay (7)

Absent (2)

Source provenance